Short answer
Humana (HUM) filed an 8-K current report with the SEC on November 17, 2026 reporting Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2). Humana announced pricing terms for its cash tender offer covering certain outstanding debt securities.
Humana 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Humana announced pricing terms for its cash tender offer covering certain outstanding debt securities
- Tender offer expired November 16, 2026, with results disclosed in Exhibit 99.2
- Debt repurchase may affect outstanding borrowings, interest expense, liquidity and capital structure
Item EX-99.1 · Exhibit EX-99.1
- Cash tender offers target up to $1.5B of outstanding debt, reducing Humana’s funded obligations if fully completed
- Acceptance priority favors 2.150% 2032 notes through 3.950% 2027 notes, creating potential proration for lower-priority tenders
- 5.375% 2031 notes capped at $800M, despite $1.5B outstanding, limiting refinancing impact for that series
- Total consideration ranges from $852.68 to $1,005.77 per $1,000 principal, plus accrued interest
- Offers expire November 16, 2026, with settlement expected November 18, 2026
Item EX-99.2 · Exhibit EX-99.2
- Humana completed cash tenders for seven debt series, accepting approximately $1.47B principal across fully accepted notes
- April 2031 Notes: $858.514M tendered, $198.661M accepted at approximately 23.74% proration
- February 2032 Notes had highest priority, with $248.416M accepted at $852.68 per $1,000 principal
- Settlement scheduled November 18, 2026, with accepted holders receiving accrued coupon payments
- Transaction reduces outstanding debt, while requiring cash outlays based on stated consideration and accrued interest
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Humana 8-K filings
Get the next HUM 8-K as it lands
Follow HUM for push alerts, or ask the research agent what this filing means.